Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

H. Shah, Manisha; S. Goldner, Whitney; B. Benson, Al; Bergsland, Emily; S. Blaszkowsky, Lawrence; Brock, Pamela; Chan, Jennifer; Das, Satya; V. Dickson, Paxton; Fanta, Paul; Giordano, Thomas; R. Halfdanarson, Thorvardur; Halperin, Daniel; He, Jin; Heaney, Anthony; J. Heslin, Martin; Kandeel, Fouad; Kardan, Arash; A. Khan, Sajid; W. Kuvshinoff, Boris; Lieu, Christopher; Miller, Kimberly; G. Pillarisetty, Venu; Reidy, Diane; Agosto Salgado, Sarimar; Shaheen, Shagufta; P. Soares, Heloisa; C. Soulen, Michael; R. Strosberg, Jonathan; R. Sussman, Craig; A. Trikalinos, Nikolaos; A. Uboha, Nataliya; Vijayvergia, Namrata; Wong, Terence; Lynn, Beth; Hochstetler, Cindy

doi:10.6004/jnccn.2021.0032

Public

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Shared by NobleBlocks on Jul 1, 2021 • 12:00 AM UTC

Authors:

Manisha H. Shah

Whitney S. Goldner

Al B. Benson

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia. NETs a...

Discussions